| 000 | 01319 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250512075008.0 | ||
| 264 | 0 | _c19850528 | |
| 008 | 198505s 0 0 eng d | ||
| 022 | _a0174-4879 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDavies, B E | |
| 245 | 0 | 0 |
_aBioavailability and pharmacokinetics of clavulanic acid in healthy subjects. _h[electronic resource] |
| 260 |
_bInternational journal of clinical pharmacology, therapy, and toxicology _cFeb 1985 |
||
| 300 |
_a70-3 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xmetabolism |
| 650 | 0 | 4 | _aBiological Availability |
| 650 | 0 | 4 | _aClavulanic Acid |
| 650 | 0 | 4 |
_aClavulanic Acids _xadministration & dosage |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRandom Allocation |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _abeta-Lactamase Inhibitors |
| 700 | 1 | _aCoates, P E | |
| 700 | 1 | _aClarke, J G | |
| 700 | 1 | _aThawley, A R | |
| 700 | 1 | _aSutton, J A | |
| 773 | 0 |
_tInternational journal of clinical pharmacology, therapy, and toxicology _gvol. 23 _gno. 2 _gp. 70-3 |
|
| 999 |
_c3878534 _d3878534 |
||